Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Drug safety

Analysis and mining of adverse events associated with vorapaxar: A FAERS database-based study

Hui Zhang, Minghao Lin, Chaoqun Song, Zheng Nan, Dexi Zhao, Yujuan Fu

published 13 Feb 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Safety population size and duration of exposure prior to approval of new medicines: A database analysis of medicines centralised approved in the European Union between 2011 and 2023

Luísa Bouwman, Hubert Leufkens, Bruno Sepodes, Carla Torre

published 09 Feb 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Disproportionality analysis of drug-associated progressive multifocal leukoencephalopathy using spontaneous reports: A 20-year signal detection study based on the FAERS database

Hailong Wang, Xinyi Li, Lijuan Shangguan

published 03 Feb 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Systematic analysis of proton pump inhibitors-related adverse reactions using the FDA adverse event reporting system database

Zhenyu Wang, Jianan Jin, Guimei Wang, Guoqi Zhou, Hanliang Jiang

published 02 Feb 2026

Loading metrics information...

Metrics unavailable. Please check back later.

An interpretable machine learning framework for adverse drug reaction prediction from drug-target interactions

Joseph Roberts-Nuttall, Alan M. Jones, Marco Castellani, Duc Pham

published 30 Jan 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Exploring adverse events associated with vosoritide monotherapy: Insights from the FDA Adverse Event Reporting System

Xiaomin Li, Xiangli Luo, Fei Liu, Chaolu Wang, Xiaoming Li, Huaixi Yu

published 29 Jan 2026

Loading metrics information...

Metrics unavailable. Please check back later.

SmUDo (Smart Unit-Dose): Redefining efficiency, quality, and staffing strategies for optimized processes

Jana Gerstmeier, Saskia Herrmann, Annika Demuth, Natalie Vuong, Olaf Kannt, Dominic Fenske

published 16 Jan 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Endocrine advantages of PD-1/PD-L1 therapy: Comparative analysis of FAERS-JADER

Yuxuan Gao, Shiyao Jiang, Yu Cui, Yumeng Wang, Lili Yu

published 09 Jan 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Suicide adverse events associated with zopiclone and eszopiclone: A pharmacovigilance analysis based on FAERS, JADER and CVARD

Yinpeng Xu, Fang Li, Mei Zhang, Li Huang

published 08 Jan 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Adverse events associated with cyclophosphamide: A pharmacovigilance study using the FDA adverse event reporting system

Hui Zhang, Minghao Lin, Dexi Zhao, Yujuan Fu

published 06 Jan 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Collaborative and co-Ordinated action for Medication Safety (COMS): Experience-based co-design of an intervention blueprint to improve general practice and community pharmacy collaboration

Penny J. Lewis, Christopher J. Armitage, Darren M. Ashcroft, Tom Blakeman, Fay Bradley, Kyle Jarman, Mark Jeffries, Rebecca Morris, Denham Phipps, Andrea D. Short, Steven D. Williams

published 26 Dec 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Patient safety risk associated with synchronous telehealth: A scoping review

Juliana Salomão Rocha de Oliveira, Rafael Saad Fernandez, Mônica Rossatti Molina, Ana Carolina P.N. Pinto, César Ramos Rocha-Filho, Tiago M. Ferreira, Stela Verzinhasse Peres

published 16 Dec 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Safety profile of TNF- alpha Inhibitors in pediatric patients: A post-marketing surveillance study based on the FAERS database

Yanmo Yang, Peng Wang, Qin-xuan Li

published 02 Dec 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Drug safety

You can change these options by clicking profile then "Alerts and Notifications"